918 related articles for article (PubMed ID: 22424133)
21. Hypoxia inducible factor-1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury.
Natarajan R; Salloum FN; Fisher BJ; Kukreja RC; Fowler AA
Circ Res; 2006 Jan; 98(1):133-40. PubMed ID: 16306444
[TBL] [Abstract][Full Text] [Related]
22. Prolyl hydroxylase domain enzyme 2 is the major player in regulating hypoxic responses in rheumatoid arthritis.
Muz B; Larsen H; Madden L; Kiriakidis S; Paleolog EM
Arthritis Rheum; 2012 Sep; 64(9):2856-67. PubMed ID: 22488178
[TBL] [Abstract][Full Text] [Related]
23. Expression of prolyl hydroxylases (PHDs) is selectively controlled by HIF-1 and HIF-2 proteins in nucleus pulposus cells of the intervertebral disc: distinct roles of PHD2 and PHD3 proteins in controlling HIF-1α activity in hypoxia.
Fujita N; Markova D; Anderson DG; Chiba K; Toyama Y; Shapiro IM; Risbud MV
J Biol Chem; 2012 May; 287(20):16975-86. PubMed ID: 22451659
[TBL] [Abstract][Full Text] [Related]
24. Short-term effects of pharmacologic HIF stabilization on vasoactive and cytotrophic factors in developing mouse brain.
Schneider C; Krischke G; Keller S; Walkinshaw G; Arend M; Rascher W; Gassmann M; Trollmann R
Brain Res; 2009 Jul; 1280():43-51. PubMed ID: 19450570
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of the catalytic activity of hypoxia-inducible factor-1alpha-prolyl-hydroxylase 2 by a MYND-type zinc finger.
Choi KO; Lee T; Lee N; Kim JH; Yang EG; Yoon JM; Kim JH; Lee TG; Park H
Mol Pharmacol; 2005 Dec; 68(6):1803-9. PubMed ID: 16155211
[TBL] [Abstract][Full Text] [Related]
26. Molecular evolution of the metazoan PHD-HIF oxygen-sensing system.
Rytkönen KT; Williams TA; Renshaw GM; Primmer CR; Nikinmaa M
Mol Biol Evol; 2011 Jun; 28(6):1913-26. PubMed ID: 21228399
[TBL] [Abstract][Full Text] [Related]
27. Expressions of individual PHDs associate with good prognostic factors and increased proliferation in breast cancer patients.
Peurala E; Koivunen P; Bloigu R; Haapasaari KM; Jukkola-Vuorinen A
Breast Cancer Res Treat; 2012 May; 133(1):179-88. PubMed ID: 21877141
[TBL] [Abstract][Full Text] [Related]
28. Chronic inhibition of hypoxia-inducible factor prolyl 4-hydroxylase improves ventricular performance, remodeling, and vascularity after myocardial infarction in the rat.
Bao W; Qin P; Needle S; Erickson-Miller CL; Duffy KJ; Ariazi JL; Zhao S; Olzinski AR; Behm DJ; Pipes GC; Jucker BM; Hu E; Lepore JJ; Willette RN
J Cardiovasc Pharmacol; 2010 Aug; 56(2):147-55. PubMed ID: 20714241
[TBL] [Abstract][Full Text] [Related]
29. An activator of PHD2, KRH102140, decreases angiogenesis via inhibition of HIF-1α.
Nepal M; Gong YD; Park YR; Soh Y
Cell Biochem Funct; 2011 Mar; 29(2):126-34. PubMed ID: 21287578
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of a prolyl hydroxylase domain (PHD) by substrate analog peptides.
Kwon HS; Choi YK; Kim JW; Park YK; Yang EG; Ahn DR
Bioorg Med Chem Lett; 2011 Jul; 21(14):4325-8. PubMed ID: 21665470
[TBL] [Abstract][Full Text] [Related]
31. Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases.
Knowles HJ; Tian YM; Mole DR; Harris AL
Circ Res; 2004 Jul; 95(2):162-9. PubMed ID: 15192023
[TBL] [Abstract][Full Text] [Related]
32. Role of the intracellular localization of HIF-prolyl hydroxylases.
Yasumoto K; Kowata Y; Yoshida A; Torii S; Sogawa K
Biochim Biophys Acta; 2009 May; 1793(5):792-7. PubMed ID: 19339211
[TBL] [Abstract][Full Text] [Related]
33. Hinokitiol activates the hypoxia-inducible factor (HIF) pathway through inhibition of HIF hydroxylases.
Lee MJ; Kim JW; Yang EG
Biochem Biophys Res Commun; 2010 May; 396(2):370-5. PubMed ID: 20416277
[TBL] [Abstract][Full Text] [Related]
34. Expression of prolyl-hydroxylase-1 (PHD1/EGLN2) suppresses hypoxia inducible factor-1alpha activation and inhibits tumor growth.
Erez N; Milyavsky M; Eilam R; Shats I; Goldfinger N; Rotter V
Cancer Res; 2003 Dec; 63(24):8777-83. PubMed ID: 14695194
[TBL] [Abstract][Full Text] [Related]
35. Essential role for prolyl hydroxylase domain protein 2 in oxygen homeostasis of the adult vascular system.
Takeda K; Cowan A; Fong GH
Circulation; 2007 Aug; 116(7):774-81. PubMed ID: 17646578
[TBL] [Abstract][Full Text] [Related]
36. Novel drugs and the response to hypoxia: HIF stabilizers and prolyl hydroxylase.
Nangaku M; Kojima I; Tanaka T; Ohse T; Kato H; Fujita T
Recent Pat Cardiovasc Drug Discov; 2006 Jun; 1(2):129-39. PubMed ID: 18221080
[TBL] [Abstract][Full Text] [Related]
37. Neuron-specific prolyl-4-hydroxylase domain 2 knockout reduces brain injury after transient cerebral ischemia.
Kunze R; Zhou W; Veltkamp R; Wielockx B; Breier G; Marti HH
Stroke; 2012 Oct; 43(10):2748-56. PubMed ID: 22933585
[TBL] [Abstract][Full Text] [Related]
38. Selective inhibition of hypoxia-inducible factor (HIF) prolyl-hydroxylase 1 mediates neuroprotection against normoxic oxidative death via HIF- and CREB-independent pathways.
Siddiq A; Aminova LR; Troy CM; Suh K; Messer Z; Semenza GL; Ratan RR
J Neurosci; 2009 Jul; 29(27):8828-38. PubMed ID: 19587290
[TBL] [Abstract][Full Text] [Related]
39. Hypoxia-inducible factors in the first trimester human lung.
Groenman F; Rutter M; Caniggia I; Tibboel D; Post M
J Histochem Cytochem; 2007 Apr; 55(4):355-63. PubMed ID: 17189520
[TBL] [Abstract][Full Text] [Related]
40. PHD1 interacts with ATF4 and negatively regulates its transcriptional activity without prolyl hydroxylation.
Hiwatashi Y; Kanno K; Takasaki C; Goryo K; Sato T; Torii S; Sogawa K; Yasumoto K
Exp Cell Res; 2011 Dec; 317(20):2789-99. PubMed ID: 21951999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
